<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:06:02Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/19447" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/19447</identifier><datestamp>2026-09-24T06:55:59Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Sheardown, Heather</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Wells, Laura</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Chemical Engineering</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2016-06-02T18:52:51Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2016-06-02T18:52:51Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2010-11</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/19447</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/20593</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p> Photoresponsive polymers can act as controllable drug delivery systems that may&#xd;
revolutionize ophthalmic drug delivery for disease treatment in the posterior segment of&#xd;
the eye. Localized, controlled drug delivery devices have significant therapeutic&#xd;
advantages for treating diseases of back of the eye by increasing patient compliance and&#xd;
maintaining therapeutic levels of drug in the tissue. Sustained-release delivery systems&#xd;
that respond to light/laser stimuli are under development to control the rate of delivery&#xd;
resulting in a tuneable treatment profile ideal for retinal diseases. The use of light as a&#xd;
crosslinking mechanism has the potential to create unique materials with controllable&#xd;
swelling, degradation and diffusion properties. &lt;/p> &lt;p> This thesis investigates the synthesis and development of universal, graftable&#xd;
PEG-anthracene molecules and their applications in photosensitive alginate and&#xd;
hyaluronate (HA) "photogels". Anthracene undergoes reversible dimerization with&#xd;
wavelengths above 300 nm and de-dimerization/dissociation below 300 nm; due to its&#xd;
well-understood chemistry and symmetry, it was used as a starting point and proof-ofconcept&#xd;
for the synthesis of reversible dimerizing crosslinkers that may be generically&#xd;
grafted to different polymers to cause crosslinking/decrosslinking. After synthesis, watersoluble&#xd;
PEG-anthracene macromolecules were grafting via carbodiimide chemistry to the&#xd;
carboxyl groups along the polymer backbone of alginate and HA at various densities to&#xd;
create viscous liquids or gels with good handling properties. &lt;/p> &lt;p> Light irradiation can be used to control the swelling and effective crosslinking&#xd;
density of the photogels which in tum can control drug delivery from photocrosslinked hydro gels as illustrated through the decrease or increase in the delivery of a variety of low&#xd;
molecular weight (&lt;1000 Da) and high molecular weight (>10,000 Da) model drug&#xd;
compounds from both alginate and HA photogels with various light treatments. Novel&#xd;
loading mechanisms were developed through the loading of compounds into&#xd;
uncrosslinked gels followed by crosslinking 365 nm exposures to "lock" in the model&#xd;
drug compounds. Diffusion coefficients effectively compared the different systems&#xd;
showing increase exposures of 365 nm resulted in greater decrease in release of&#xd;
compounds demonstrating the ability to fine-tune release rates. Different formulations&#xd;
and control gels demonstrate a variety of different release profiles. The photogels were&#xd;
valuable long-term controlled release systems (>80 days) that also demonstrate high&#xd;
cytocompatibility when grown with ophthalmic cell lines. &lt;/p> &lt;p> Novel photoresponsive biomaterials for smart delivery of therapeutics which use&#xd;
light-controlled crosslinking and decrosslinking mechanisms have been developed. The&#xd;
PEG-anthracene graftable photocrosslinkers show the ability to introduce photocontrolled&#xd;
crosslinking into hydrogel systems. While anthracene as the photodimerizer&#xd;
and alginate and HA as the bulk materials are used as a proof-of-concept in this work, this&#xd;
grafting system can be further manipulated to include new photosensitive dimerizers and&#xd;
other applicable polymers. The ability to use light stimuli to control release rates in a&#xd;
continual fashion, rather than having delivery that is strictly on or off, is a valuable&#xd;
finding that may lead to the development of drug delivery systems that can be catered&#xd;
towards individuals and the progression of their disease. &lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Photoresponsive</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">polymer</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">drug delivery</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">ophthalmic drug delivery</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">disease treatment</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Photoresponsive Drug Delivery From Anthracrene-Modified Hydrogels</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>